Skip to main content
Clinical Trials/NCT07179731
NCT07179731
Not yet recruiting
Not Applicable

Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and Their Combination in the Management of Postoperative Pain in Laparoscopic Cholecystectomy Surgery

Istanbul Medeniyet University0 sites105 target enrollmentStarted: September 23, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Istanbul Medeniyet University
Enrollment
105
Primary Endpoint
Postoperative Analgesic Consumption

Overview

Brief Summary

This study aims to compare the efficacy of Subcostal Transversus Abdominis Plan Block, External Oblique Intercostal Plan Block and the combination of these two blocks, which are used in anesthesiology practice for postoperative pain in laparoscopy cholecystectomy surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients scheduled for laparoscopic cholecystectomy surgery
  • Patients aged between 18 to 80 years
  • Having an anesthesiology risk assessment of ASA I, II, or III

Exclusion Criteria

  • Patients who do not give written and oral consent
  • Patients with coagulopathy
  • History of allergic reaction or intoxication by local anesthetics
  • Severe organ failure
  • Mental retardation or illiteracy
  • Presence of infection on the injection site
  • Pregnancy
  • Patients whom the procedure is extended to open cholecystectomy

Outcomes

Primary Outcomes

Postoperative Analgesic Consumption

Time Frame: 24 hours postoperatively

The opioid consumption via patient controlled analgesia (PCA) in 24 hours postoperatively

Secondary Outcomes

  • Postoperative Pain Scores(up to 24 hours after surgery)

Investigators

Sponsor
Istanbul Medeniyet University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Faruk Komez

MD

Istanbul Medeniyet University

Similar Trials